Key Highlights

• Eastman Chemical's $0.84 quarterly Dividend trades ex-date and Record Date September 15, 2026, payable October 7, yielding approximately 4.80%.

• The company has increased its dividend for 17 consecutive years, with the current $0.84 rate up from $0.83 in 2025.

• Second-quarter sales Revenue rose to $2.513 billion from $2.287 billion, with adjusted EPS increasing to $1.97 from $1.60.

• Adjusted EBIT Margin expanded 350 basis points sequentially.

Eastman Chemical's (NYSE:EMN) $0.84 quarterly dividend trades ex-date and record date September 15, payable October 7. Sales revenue rose to $2.513 billion from $2.287 billion, with adjusted EPS increasing to $1.97 from $1.60, and management citing strong volume, mix and price-cost management alongside progress toward a $125-150 million cost-savings target.

Dividend Program and Shareholder Returns

Eastman Chemical declared a $0.84 per share quarterly dividend, payable October 7 to shareholders of record and ex-dividend date September 15. The annualized dividend is $3.36 per share, up from $3.32 in 2025, extending a 17-year streak of consecutive increases.

About the Company

Eastman Chemical is a global specialty-materials and chemicals company founded in 1920, supplying products across transportation, building and construction, consumables, coatings, adhesives, packaging and health care.

Financial Performance Behind the Payout

Eastman reported second-quarter sales revenue of $2.513 billion, up from $2.287 billion a year earlier. EBIT increased to $311 million from $222 million, while adjusted EBIT was $320 million compared with $275 million. Diluted EPS rose to $1.59 from $1.20, and adjusted EPS increased to $1.97 from $1.60. Operating Cash Flow was $224 million, slightly below $233 million in Q2 2025. Management cited strong Volume and mix, disciplined price-cost management, spread expansion in Chemical Intermediates, and progress toward a $125-150 million cost-savings target net of inflation. Circular-economy platform revenue doubled in the first half of 2026, with the Kingsport methanolysis Facility continuing its commercial ramp.

Outlook

Continued adjusted EBIT margin trends, progress toward the $125-150 million cost-savings target, and the Kingsport methanolysis facility's commercial ramp as a signal of circular-platform scale are the items management has cited for tracking ahead.